Breaking News

IDT Biologika, Oncotec Invest in Expansion Projects

To expand vaccine and oncology capacity at IDT’s BioPharmaPark

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

IDT Biologika GmbH and Oncotec Pharma Produktion have made several investments to increase their respective production capacities. IDT will invest €40 million in its vaccine and parenteral sterile fill-and-finish capacities in syringes, vials, lyophilization, and packaging at its BioPharmaPark in Dessau-Roβlau. Among the upgrades are new serialization and anti-counterfeiting capabilities designed to enable the authentication of finished pharmaceuticals. IDT also recently started up its new produ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters